Rani Therapeutics Holdings, Inc. (RANI) Profit Margin
Rani Therapeutics Holdings, Inc. (RANI) net profit margin by fiscal period. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2021-12-31 | -306.62% |
| 2022-12-31 | N/A |
| 2023-12-31 | N/A |
| 2024-12-31 | -2920.04% |
| 2025-12-31 | -1817.09% |
How RANI compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| NTLA | Intellia Therapeutics Inc. | -609.85% |
| VSTM | Verastem Inc. | -677.59% |
| AGIO | Agios Pharmaceuticals Inc. | -764.01% |
| XBIT | XBiotech Inc. | -820.45% |
| DMAC | DiaMedica Therapeutics Inc. | -1146.80% |
These are five companies in the same sector as RANI with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Rani Therapeutics Holdings, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("RANI", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | RANI | $0.82 | +3.07% | 2.58M |
| 3 | ||||
| 4 | ||||
| 5 |